Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Chicago, Illinois Clinical Trials

A listing of Chicago, Illinois clinical trials actively recruiting patient volunteers.

RESULTS

Found (1786) clinical trials

Esophageal String Test in Eosinophilic Esophagitis

Eosinophilic esophagitis (EoE) is an increasingly recognized rare disease of children and adults characterized by symptoms including nausea, vomiting, abdominal pain, dysphagia and food impaction that occur in conjunction with esophageal eosinophilia. To date, the only method to make EoE diagnoses and follow treatment responses in EoE is invasive endoscopy ...

Phase N/A

0.0 miles

Learn More »

In Home VR Therapy

Virtual reality is a video game in which a person and their real-time movements are represented on a screen in a virtual environment. This study will compare the use of multi-user virtual reality (VR) to single-user VR to determine if either provides superior engagement in upper extremity therapy and greater ...

Phase N/A

0.0 miles

Learn More »

A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery

The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further ...

Phase N/A

0.43 miles

Learn More »

STeroids to REduce Systemic Inflammation After Neonatal Heart Surgery

Overview Congenital heart diseases (CHD) are the most common birth defects, occurring in nearly 1% of live births. Every year, an estimated 40,000 infants born in the U.S. suffer from CHD. Despite advances in surgical management, CHD requiring neonatal surgery is associated with poor outcomes; national registry data demonstrates post-operative ...

Phase

0.47 miles

Learn More »

A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies (PLATFORM)

This is a global, open-label, multi-arm, multi-cohort, multi-center, Phase 1/2 study to determine the safety, tolerability, PK, efficacy and patient reported quality of life of JCAR017 in combination with various agents. This protocol is intended to evaluate various drug combinations with JCAR017, as separate arms, over the life of the ...

Phase

0.47 miles

Learn More »

REmodeling the Left Ventricle With Atrial Modulated Pacing

New therapy tested in heart failure with preserved ejection fraction (HFpEF) patients with approved indications for pacing to determine if elevated pacing therapy is tolerated and whether there is a signal for efficacy.

Phase N/A

0.47 miles

Learn More »

Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor

OBJECTIVES: Primary - To determine the response to second curettage in patients with persistent, non-metastatic gestational trophoblastic neoplasia (GTN). Secondary - To evaluate if response to a second curettage is independent of the tumor burden as measured by the quantitative beta-human chorionic gonadotropin (hCG) assay at study entry. - To ...

Phase

0.47 miles

Learn More »

Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

OBJECTIVES Provide supervised access to treatment with yttrium Y 90 glass microspheres (TheraSphere) to eligible patients with cancer of the liver who are not candidates for surgical resection. Evaluate patient experience and toxicities associated with yttrium Y 90 glass microspheres (TheraSphere) treatment. OUTLINE: This is a humanitarian device exemption use ...

Phase N/A

0.47 miles

Learn More »

Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

OBJECTIVES Provide supervised access to treatment with yttrium Y 90 glass microspheres (TheraSphere) to eligible patients who are not candidates for surgical resection of metastatic intrahepatic carcinoma. Evaluate patient experience and toxicities associated with yttrium Y 90 glass microspheres treatment. OUTLINE: This is a humanitarian device exemption use study. Patients ...

Phase N/A

0.47 miles

Learn More »

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma Acral Melanoma or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

OBJECTIVES: Primary - To estimate the objective tumor response rate in patients with KIT-positive, unresectable, locally advanced or metastatic acral or mucosal melanoma treated with dasatinib monotherapy. Secondary - To estimate the response duration in patients treated with this drug. - To estimate the progression-free survival of patients treated with ...

Phase

0.47 miles

Learn More »